ID: ALA5198554

Max Phase: Preclinical

Molecular Formula: C14H16FNO2

Molecular Weight: 249.28

Associated Items:

Representations

Canonical SMILES:  CC(C)(C)CCN1C(=O)C(=O)c2cc(F)ccc21

Standard InChI:  InChI=1S/C14H16FNO2/c1-14(2,3)6-7-16-11-5-4-9(15)8-10(11)12(17)13(16)18/h4-5,8H,6-7H2,1-3H3

Standard InChI Key:  BXKLRQNWWNEHHA-UHFFFAOYSA-N

Associated Targets(Human)

PARK7 Tbio Parkinson disease protein 7 (54 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 249.28Molecular Weight (Monoisotopic): 249.1165AlogP: 2.79#Rotatable Bonds: 2
Polar Surface Area: 37.38Molecular Species: NEUTRALHBA: 2HBD: 0
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 2.87CX LogD: 2.87
Aromatic Rings: 1Heavy Atoms: 18QED Weighted: 0.76Np Likeness Score: -1.08

References

1. Maksimovic I, Finkin-Groner E, Fukase Y, Zheng Q, Sun S, Michino M, Huggins DJ, Myers RW, David Y..  (2021)  Deglycase-activity oriented screening to identify DJ-1 inhibitors.,  12  (7.0): [PMID:34355187] [10.1039/D1MD00062D]

Source